CARDIOCELL
Founded in San Diego, Calif., in 2013, CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique patented ischemia-tolerant mesenchymal stem cells (itMSCs) manufactured under cGMP conditions. CardioCell has an exclusive worldwide license from its parent company, Stemedica, for exploration of therapeutic indications in the cardiovascular field, which includes such indications as acute myocardial Infarction (AMI), chronic heart failure (CHF) and peripheral artery disease (PAD).
CARDIOCELL
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2013-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.stemcardiocell.com
Total Employee:
1+
Status:
Active
Contact:
(858) 875-6569
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Microsoft Exchange Online
Similar Organizations
ACS Global
ACS Global offers services for individuals to privately preserve their stem cells for potential future use in cell therapy.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.stemcardiocell.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K
- Host name: 172.67.200.195
- IP address: 172.67.200.195
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CardioCell"
CardioCell - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (858) 875-6569 Founded in San Diego, Calif., in 2013, CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique patented ischemia-tolerant …See details»
www.stemcardiocell.com
Www.stemcardiocell.comSee details»
CardioCell - Overview, News & Similar companies | ZoomInfo.com
Who is CardioCell. Founded in San Diego, California, in 2013, CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique, paten ted, ischemia …See details»
CardioCell Company Profile 2024: Valuation, Funding & Investors
CardioCell General Information Description. Developer of a biotechnology company designed for therapeutic applications of unique patented stem cells. The company develops therapeutic …See details»
CardioCell Company Profile - Office Locations, Competitors, …
CardioCell is a global biotechnology company that explores therapeutic applications of patented ischemia-tolerant mesenchymal stem cells (itMSCs) manufactured under current good …See details»
Stem cells and the heart: ethics, organization and funding
The unprecedented nature of the discovery of a therapeutic role for autologous stem cells brings with it unprecedented challenges in clinical application of basic biology, ethics, funding and ...See details»
www.stemcardiocell.com
Disclaimer: References to any specific company, product or services on this Site are not controlled by GoDaddy.com LLC and do not constitute or imply its association with or …See details»
CardioCell - Company Profile - Tracxn
Oct 22, 2024 CardioCell - Mesenchymal stem cells based therapy for different cardiovascular indications such as acute myocardial infarction.. Raised a total funding of $1.06M over 1 …See details»
CardioCell Reports Positive Results From the First Phase IIa Clinical ...
ROME, Aug. 28, 2016 /PRNewswire/ -- EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2016 -- Study sponsor CardioCell LLC, a global biotechnology company that uses allogeneic …See details»
Stem Cells in Cardiovascular Medicine: Historical Overview and …
Nov 27, 2019 1. Introduction. Cardiovascular diseases (CVDs) remain a plight to modern-day humans, accounting for over one-third of all deaths worldwide, according to recent World …See details»
Stem cells: a new way of therapy for cardiovascular disorders
Nov 3, 2020 Introduction. Cardiovascular diseases are those severe and life threatening disorders that reduce the life span of a person and ultimately affect the quality of its life ().In …See details»
Stem cell therapies in cardiac diseases: Current status and future ...
Sep 26, 2021 Cardiovascular diseases represent the world's leading cause of death. In this heterogeneous group of diseases, ischemic cardiomyopathies are the most devastating and …See details»
Stem cells and the heart—the road ahead | Science - AAAS
Feb 21, 2020 In retrospect, the lack of efficacy in these adult cell trials might have been predicted. The most common cell type delivered has been bone marrow mononuclear cells, …See details»
Stem cell therapy for cardiac regeneration: past, present, and future
Jan 16, 2024 Cardiac disorders remain the leading cause of mortality worldwide. Current clinical strategies, including drug therapy, surgical interventions, and organ transplantation offer …See details»
Cardiac Stem Cell Biology | Circulation Research - AHA/ASA Journals
Jan 3, 2014 Cardiac regeneration strategies and de novo generation of cardiomyocytes have long been significant areas of research interest in cardiovascular medicine. In this review, we …See details»
Rejuvenating cells to repair damaged hearts - Heart and Stroke ...
Dr. Ren-Ke Li had high hopes for the clinical trial that would apply his research discovery aimed at benefitting people with heart failure. He had spent years developing a way to use the body’s …See details»
Cardiac Tissues From Stem Cells | Circulation Research - AHA/ASA …
Mar 18, 2021 The ability of human pluripotent stem cells to form all cells of the body has provided many opportunities to study disease and produce cells that can be used for therapy …See details»
State‐of‐play for cellular therapies in cardiac repair and …
Aug 27, 2021 The rationale for this focus is obvious. Cardiovascular disease is the primary cause of death around the world. In 2019, cardiac disease accounted for 32% of all deaths. 1 …See details»
Stem cells to help the heart | Science - AAAS
Mar 13, 2020 The hiPSC technology has had a particularly notable impact in cardiac regenerative medicine, a field where scientists and clinicians have been working to devise new …See details»
Cardioids reveal self-organizing principles of human cardiogenesis
May 20, 2021 To mimic this self-organization process in cardioids, we developed an epicardial differentiation protocol compatible with cardioids and based on the signaling sequence known …See details»